4//SEC Filing
Mulligan Richard 4
Accession 0001562180-24-006954
CIK 0001770121other
Filed
Sep 25, 8:00 PM ET
Accepted
Sep 26, 4:07 PM ET
Size
7.6 KB
Accession
0001562180-24-006954
Insider Transaction Report
Form 4
Mulligan Richard
Director
Transactions
- Sale
Common Stock
2024-09-24$4.08/sh−150,000$612,570→ 2,848,121 total - Sale
Common Stock
2024-09-25$3.89/sh−150,000$583,170→ 2,698,121 total
Footnotes (3)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 25, 2024.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.00 to $4.16, inclusive. The reporting person undertakes to provide to Sana Biotechnology, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $4.13, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001376247
Filing Metadata
- Form type
- 4
- Filed
- Sep 25, 8:00 PM ET
- Accepted
- Sep 26, 4:07 PM ET
- Size
- 7.6 KB